| 23755 | 23755 | Oxygen Supplementation During Bronchoscopy: High Flow Versus Low Flow Oxygen | Not yet recruiting | No Results Available | Hypoxia | Device: High flow nasal oxygen supplementation|Device: low flow nasal oxygen supplementation | https://ClinicalTrials.gov/show/NCT02253706 |
| 23756 | 23756 | Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of Accelerometry | Recruiting | No Results Available | Hemophilia A, Congenital | | https://ClinicalTrials.gov/show/NCT02253693 |
| 23757 | 23757 | The Use of Compression Bandages in Total Knee Replacement Surgery | Active, not recruiting | No Results Available | Osteoarthritis | Procedure: Actico, short-stretch, inelastic dressing | https://ClinicalTrials.gov/show/NCT02253680 |
| 23758 | 23758 | Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients | Not yet recruiting | No Results Available | Lung Disease|Acute Respiratory Distress Syndrome | Device: HFONC|Device: Conventional oxygen therapy | https://ClinicalTrials.gov/show/NCT02253667 |
| 23759 | 23759 | If Alternate Dosing is Superior at Maintaining Hb Between 10.0 to 11.0 g/dL in CKD Subjects on HD vs the Current USPI | Recruiting | No Results Available | Renal Insufficiency, Chronic|Anemia|Renal Dialysis|Erythrocyte Transfusion | Drug: Epoetin alfa | https://ClinicalTrials.gov/show/NCT02253654 |
| 23760 | 23760 | The STRENGTH Study: Shapely Sisters Targeting Realistic Exercise and Nutrition Goals Through Healthy Habits | Completed | No Results Available | Obesity | Behavioral: Standard Weight Loss Intervention|Behavioral: Stress-Focused Weight Loss Intervention | https://ClinicalTrials.gov/show/NCT02253641 |
| 23731 | 23731 | Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck | Completed | No Results Available | Head and Neck Neoplasms | Drug: bivatuzumab mertansine | https://ClinicalTrials.gov/show/NCT02254018 |
| 23732 | 23732 | Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer | Completed | No Results Available | Breast Neoplasms | Drug: bivatuzumab mertansine | https://ClinicalTrials.gov/show/NCT02254005 |
| 23733 | 23733 | Study of the Safety and Tolerability of Urelumab Administered in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkins Lymphoma | Recruiting | No Results Available | Advanced Solid Tumors|Advanced B-cell NHL | Biological: Urelumab|Biological: Nivolumab | https://ClinicalTrials.gov/show/NCT02253992 |
| 23734 | 23734 | Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube | Completed | No Results Available | Endotracheal Intubation|Airway Management|One Lung Ventilation | Device: Standard double lumen tube|Device: VivaSight double lumen tube | https://ClinicalTrials.gov/show/NCT02253979 |
| 23735 | 23735 | Preoperative Intraarticular Injection of Methylprednisolone in Patients Scheduled for Total Knee-arthroplasty | Recruiting | No Results Available | Knee Joint Osteoarthrosis|Hyperalgesia|Severe Movement Related Pain | Drug: Methylprednisoloneacetate|Drug: Lidocaine|Other: sodium chloride | https://ClinicalTrials.gov/show/NCT02253966 |
| 23736 | 23736 | Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BILR 355 BS, D1|Drug: BILR 355 BS, D2|Drug: BILR 355 BS, D3|Drug: BILR 355 BS, D4|Drug: BILR 355 BS, D5|Drug: BILR 355 BS, D6|Drug: BILR 355 BS, D7|Drug: BILR 355 BS, D8|Drug: BILR 355 BS, D10|Drug: Placebo|Other: high-fat breakfast|Drug: Ritonavir | https://ClinicalTrials.gov/show/NCT02253953 |
| 23737 | 23737 | Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: BILR 355 - Treatment A (current tablet formulation)|Drug: BILR 355 - Treatment B (new tablet formulation)|Drug: BILR 355 - Treatment C (new capsule formulation)|Drug: BILR 355 - Treatment D (current tablet formulation)|Drug: BILR 355 - Treatment E (new capsule formulation)|Drug: Ritonavir | https://ClinicalTrials.gov/show/NCT02253940 |
| 23738 | 23738 | Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: BILR 355 - D1|Drug: BILR 355 - D2|Drug: BILR 355 - D3|Drug: BILR 355 - D4|Drug: Ritonavir|Other: high fat breakfast | https://ClinicalTrials.gov/show/NCT02253927 |
| 23739 | 23739 | Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers | Completed | No Results Available | Healthy | Drug: BILR 355 BS, solution|Drug: BILR 355 BS, tablet|Drug: Ritonavir|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02253914 |
| 23740 | 23740 | Pharmacokinetic Interaction Between TRUVADAâ„¢ and BILR 355 BS Plus Ritonavir in Healthy Volunteers | Completed | No Results Available | Healthy | Drug: BILR 355 BS|Drug: Ritonavir|Drug: TRUVADA | https://ClinicalTrials.gov/show/NCT02253901 |
| 23741 | 23741 | Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers | Completed | No Results Available | Healthy | Drug: TPV - Room condition|Drug: TPV - Refrigerated conditions|Drug: Ritonavir (RTV) | https://ClinicalTrials.gov/show/NCT02253888 |
| 23742 | 23742 | Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers | Completed | No Results Available | Healthy | Drug: Tipranavir (TPV)|Drug: Ritonavir|Drug: Omeprazole | https://ClinicalTrials.gov/show/NCT02253875 |
| 23743 | 23743 | Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers | Completed | No Results Available | Healthy | Drug: Tadalafil|Drug: Tipranavir|Drug: Ritonavir | https://ClinicalTrials.gov/show/NCT02253862 |
| 23744 | 23744 | Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers | Completed | No Results Available | Healthy | Drug: Carbamazepine|Drug: Tipranavir|Drug: Ritonavir | https://ClinicalTrials.gov/show/NCT02253849 |
| 23745 | 23745 | Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir | Completed | No Results Available | Healthy | Drug: Tipranavir|Drug: Ritonavir|Drug: Atazanavir | https://ClinicalTrials.gov/show/NCT02253836 |
| 23746 | 23746 | Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers | Completed | No Results Available | Healthy | Drug: EFV|Drug: TPV/RTV - low dose|Drug: TPV/RTV - high dose | https://ClinicalTrials.gov/show/NCT02253823 |
| 23747 | 23747 | Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy | Enrolling by invitation | No Results Available | Dysplasia, Congenital Hip | Drug: Tranexamic Acid|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02253810 |
| 23748 | 23748 | Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects | Completed | No Results Available | Healthy | Drug: 14C-Tipranavir|Drug: Tipranavir|Drug: Ritonavir | https://ClinicalTrials.gov/show/NCT02253797 |
| 23749 | 23749 | Comparison Between Perineural and Systemic Effect of Dexamethasone as an Adjuvant for Prolongation of Four Nerve Blocks With Bupivacaine in Total Knee Arthroplasty | Not yet recruiting | No Results Available | Analgesia|Pain, Postoperative | Drug: Dexamethasone|Drug: Bupivacaine | https://ClinicalTrials.gov/show/NCT02253784 |
| 23750 | 23750 | Shockwave Therapy for Acute Low Back Pain | Recruiting | No Results Available | Acute Low Back Pain (Low Back Pain for Less Than 3 Months) | Device: shockwave therapy | https://ClinicalTrials.gov/show/NCT02253771 |
| 23751 | 23751 | Arousal Pathways and Emergence From Sedation | Not yet recruiting | No Results Available | Anesthesia | Drug: Propofol | https://ClinicalTrials.gov/show/NCT02253758 |
| 23752 | 23752 | Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) | Completed | No Results Available | ADHD | Drug: V81444|Drug: Placebo | https://ClinicalTrials.gov/show/NCT02253745 |
| 23753 | 23753 | Skeletal Muscle as a Mediator of Exercise Induced Effects on Metabolism & Cognitive Function: Role for Myokines & miRNAs | Recruiting | No Results Available | Mild Cognitive Impairment|Alzheimer Disease|Parkinson Disease|Healthy Volunteers | Behavioral: 3 months exercise intervention program | https://ClinicalTrials.gov/show/NCT02253732 |
| 23754 | 23754 | Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia | Not yet recruiting | No Results Available | Cervical Neoplasia|Cervical Cancer | Procedure: cryotherapy, further biopsy, LEEP, surgery as indicated | https://ClinicalTrials.gov/show/NCT02253719 |